CMTA Appoints Biotech Industry Veteran Suzanne Bruhn, PhD as New CEO
GLENOLDEN, PA / ACCESSWIRE / November 6, 2023 / The Charcot-Marie-Tooth Association announced Nov. 6 that Suzanne (Sue) Bruhn, PhD,...
Year: 2023
SENATE MOVES TO END RAPE KIT BACKLOG: Votes to Renew Debbie Smith Act-Most Effective Anti-Rape Legislation
Washington, D.C.--(Newsfile Corp. - November 6, 2023) - The U.S. Senate voted to renew the Debbie Smith Act, a law...
KelaHealth Surgical Intelligence Platform Helps Surgeons Avoid Serious Complications
Real-time deployment of AI tool in Duke Colorectal Surgery workflows leads to a reduction in AKI and readmissions in new...
Edifecs to Speak on the Power of Artificial Intelligence at 2023 WEDI National Conference
Learn how AI unlocks a new level of value-based care and clinical decisions supportBELLEVUE, Wash.--(BUSINESS WIRE)--Edifecs, Inc., a global health...
Britannia Provides Update on Mining Division Including Britannia Mining Solutions and Paragon Geochemical
Britannia Mining Solutions is a partially owned subsidiary of Britannia Life SciencesBritannia Mining Solutions owns Paragon Geochemical, a full-service, state-of-the-art...
BioStem Technologies to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023
POMPANO BEACH, FL / ACCESSWIRE / November 6, 2023 / BioStem Technologies Inc. (OTC PINK:BSEM), a leading regenerative medicine company...
Ainos Signs MoU for Contract Clinical Trials to Conduct Clinical Study of Potential New Animal Drug Based on VELDONA
Ainos and SIDSCO will cooperate to accelerate the development of new animal drugs based on Ainos' VELDONA® low-dose oral interferonUpcoming...
Gemina Labs Ltd Appoints Stifel as Financial Advisor
VANCOUVER, BC / ACCESSWIRE / November 6, 2023 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7), a diagnostics technology company, is pleased to...
SELLAS Life Sciences Presents Positive Key Immunobiological and Clinical Data from Phase 1/2 Trial of Galinpepimut-S (GPS) in Combination with Keytruda® in WT1+ Platinum-Resistant Advanced Ovarian Cancer at the International Gynecologic Cancer Society 2023 Annual Global Meeting
Median overall survival for GPS and Keytruda® combination was 18.4 Months compared to 13.8 Months in a Keytruda® single agent...
Desjardins Group donates $500K to the MUHC Foundation to support career training for students of the health sciences
The gift supports the Desjardins Centre for Advanced Training at the Research Institute of the McGill University Health Centre, which...
Nexcella Presents NXC-201 Data at 65th American Society of Hematology (ASH) Annual Meeting in 63 Relapsed/Refractory Multiple Myeloma Patients
95% overall response rate observed in relapsed/refractory multiple myeloma patients not previously treated with BCMA-targeted therapy98% overall response rate observed...
Novo Integrated Sciences Advised Receipt of Proceeds of RC Consulting Promissory Note Expected in 3-5 Business Days
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) today announced that RC Consulting Group LLC...
The Fourth Edition of the Longevity Investors Conference, Held in Gstaad (Switzerland), Unites Visionary Scientists, Industry Titans and Investors for Unprecedented Collaboration
The two full day event, Longevity Investors Conference, held in Gstaad, featured a diverse array of speakers, including leading scientists,...
BioNxt Solutions Reports on Barcelona CPHI Conference
VANCOUVER, BC / ACCESSWIRE / November 6, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTFF)(FSE:BXT) is pleased to...
Laxxon Medical to Attend BIO-Europe Munich 2023
NEW YORK, NY / ACCESSWIRE / November 6, 2023 / Laxxon Medical announced today its participation in the 29th annual...
Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023
- Patients in OPTIC continue to experience long-term benefit from Ixo-vec through 3 years of follow-up, including maintenance of vision,...
SYFOVRE® (pegcetacoplan injection) Continued to Demonstrate Increasing Treatment Effects Over 3 Years in Patients with Geographic Atrophy (GA)
SYFOVRE reduced nonsubfoveal GA lesion growth by over 40% (monthly) in Year 3 compared to projected sham in the GALE...
Novo Integrated Sciences Announces Issuance of Underlying One Billion Dollar Gold Backed Bond
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) today announced the issuance of the underlying...
MyndTec Inc. Completes Non-Brokered Private Placement
Mississauga, Ontario--(Newsfile Corp. - November 3, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging leader in...
Nova Mentis Applauds Government Decision to Create Rare Disease Advisory Group
Vancouver, British Columbia--(Newsfile Corp. - November 3, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF)...